191 related articles for article (PubMed ID: 15652971)
1. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
[TBL] [Abstract][Full Text] [Related]
5. Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome.
Saint-Léger E; Caumes E; Breton G; Douard D; Saiag P; Huraux JM; Bricaire F; Agut H; Fillet AM
Clin Infect Dis; 2001 Dec; 33(12):2061-7. PubMed ID: 11702291
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues.
Ostrowski T; Golankiewicz B; De Clercq E; Andrei G; Snoeck R
Eur J Med Chem; 2009 Aug; 44(8):3313-7. PubMed ID: 19339082
[TBL] [Abstract][Full Text] [Related]
7. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.
Ng TI; Shi Y; Huffaker HJ; Kati W; Liu Y; Chen CM; Lin Z; Maring C; Kohlbrenner WE; Molla A
Antimicrob Agents Chemother; 2001 Jun; 45(6):1629-36. PubMed ID: 11353604
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization.
Fillet AM; Dumont B; Caumes E; Visse B; Agut H; Bricaire F; Huraux JM
J Med Virol; 1998 Jul; 55(3):250-4. PubMed ID: 9624615
[TBL] [Abstract][Full Text] [Related]
12. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
[TBL] [Abstract][Full Text] [Related]
13. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
Machida H; Nishitani M; Ashida N
Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anti-varicella-zoster virus activity of interferon-alpha 2a and acyclovir in corneal cells.
Punda-Polić V; O'Brien WJ; Taylor JL
Zentralbl Bakteriol; 1999 Apr; 289(2):203-10. PubMed ID: 10360320
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
[TBL] [Abstract][Full Text] [Related]
16. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of propolis special extract GH 2002 against
Labská K; Plodková H; Pumannová M; Sensch KH
Pharmazie; 2018 Dec; 73(12):733-736. PubMed ID: 30522559
[TBL] [Abstract][Full Text] [Related]
19. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
[TBL] [Abstract][Full Text] [Related]
20. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]